MEGHAN GROTHUS: Open Payments
NPI 1750876751 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 27 payments from 4 companies in 2025. Trend: 2023 $295 · 2024 $131 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $331 |
| Novo Nordisk Inc | 3 | $219 |
| Biogen, Inc. | 1 | $104 |
| AstraZeneca Pharmaceuticals LP | 2 | $83 |
Products named: VRAYLAR, Wegovy, ZURZUVAE, Ozempic, BREZTRI, UBRELVY, FARXIGA, QULIPTA.
Industry payments across IA — which companies pay providers there.
